Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
High concentrated liquid Omega 3 for infants More
MRI contast medium More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms More
MRI contast medium More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Increasing the stability and improving the reconstitution of biomolecules using supercritical fluid (SCF) processing More
Crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Purified Microfine Red Sanders Wood Powder having High Drug and Colour Values: Use in Skin Therapeutics More
Related Reports
Market Research Reports provided by reports.innovaro.com
Jul 2010 - 85 pages - $750
Jul 2010 - 43 pages - $750
Nov 2010 - 22 pages - $750
Nov 2010 - 37 pages - $750
Nov 2010 - 63 pages - $750
Nov 2010 - 41 pages - $750
Nov 2010 - 24 pages - $750
Nov 2010 - 15 pages - $750
Nov 2010 - 16 pages - $750
Nov 2010 - 41 pages - $750
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Ayuverdic medicine
- Chinese medicine
- Dietetic
- Homeopathy
- Iron excess
- Kanpo medicine
- Other
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us